Cita APA

Zhu, A. X., Nipp, R. D., Finn, R. S., Galle, P. R., Llovet i Bayer, J. M., Blanc, J. F., . . . Kudo, M. (2020). Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: Patient-reported outcomes across two randomised clinical trials.

Citación estilo Chicago

Zhu, Andrew X., et al. Ramucirumab in the Second-line for Patients With Hepatocellular Carcinoma and Elevated Alpha-fetoprotein: Patient-reported Outcomes Across Two Randomised Clinical Trials. 2020.

Cita MLA

Zhu, Andrew X., et al. Ramucirumab in the Second-line for Patients With Hepatocellular Carcinoma and Elevated Alpha-fetoprotein: Patient-reported Outcomes Across Two Randomised Clinical Trials. 2020.